AH
Aviva Holdings Portfolio holdings
AUM
$20.5M
This Quarter Return
+13.94%
1 Year Return
+117.01%
3 Year Return
-36.54%
5 Year Return
-22.08%
10 Year Return
–
AUM
$616M
AUM Growth
+$616M
(+150%)
Cap. Flow
+$53.4M
Cap. Flow
% of AUM
8.67%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
2
Reduced
–
Closed
1
Top Buys
| 1 |
Esperion Therapeutics
ESPR
|
$40.5M |
| 2 |
MDCO
Medicines Co
MDCO
|
$14.9M |
| 3 |
Solid Biosciences
SLDB
|
$409K |
Top Sells
| 1 |
PTC Therapeutics
PTCT
|
$2.36M |
Sector Composition
| 1 | Healthcare | 36.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRTX
1
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $155M | 25.1% |
3,135,966
| – | – |
|
|
MDCO
2
DELISTED
Medicines Co
MDCO
| $139M | 22.51% |
3,778,742
+405,345
| +12% | +$14.9M |
|
|
3
Esperion Therapeutics
ESPR
$478M
| $47M | 7.64% |
1,200,100
+1,032,513
| +616% | +$40.5M |
|
4
MacroGenics
MGNX
$118M
| $20.2M | 3.28% |
977,426
| – | – |
|
|
5
Solid Biosciences
SLDB
$438M
| $409K | 0.07% |
+11,488
| New | +$409K |
|
|
6
PTC Therapeutics
PTCT
$4.33B
| – | – |
-87,330
| Closed | -$2.36M |
|